Alcohol consumption and the CAGE test in outpatients with schizophrenia or Schizoaffective disorder and in the general population

被引:11
|
作者
Etter, M
Etter, JF
机构
[1] Univ Geneva, Inst Social & Prevent Med, CMU, CH-1211 Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland
关键词
alcoholism; schizophrenia; schizoaffective disorder; epidemiologic studies;
D O I
10.1093/oxfordjournals.schbul.a007144
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We conducted a survey of 151 outpatients with schizophrenia or schizoaffective disorder in Geneva, Switzerland, in 2000, and a mail survey in a representative sample of the general population of Geneva in 1996 (n = 742), to compare alcohol consumption and alcoholism in these two samples. Fewer patients with schizophrenia than participants in the general population drank alcohol daily (9.9% vs. 18.3%, p < 0.001). Excluding participants who said they currently never drank, alcohol consumption was similar in both groups (3 vs. 4 glasses/week, p = 0.22). However, more patients with schizophrenia than participants in the population sample had a CAGE score >= 2 (21.2% vs. 10.1%, p < 0.001), indicating a suspicion of alcoholism. Thus, asking about alcohol consumption produced different results from assessing hidden alcoholism with the CAGE. Either patients with schizophrenia underreported their alcohol consumption, or the CAGE produced higher scores in these patients, for any given level of alcohol consumption. Previous research has shown, however, that the CAGE is a valid test in patients with schizophrenia, which suggests that in Geneva, alcoholism is more prevalent in patients with schizophrenia than in the general population.
引用
收藏
页码:947 / 956
页数:10
相关论文
共 50 条
  • [1] Is moderate alcohol consumption safe in patients with schizophrenia/schizoaffective disorder?
    Sweeting, MJ
    Dore, G
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 : A142 - A142
  • [2] Alcohol consumption and CAGE test in out patients with schizophrenia
    Etter, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S225 - S225
  • [3] Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population
    Etter, M
    Mohr, S
    Garin, C
    Etter, JF
    SCHIZOPHRENIA BULLETIN, 2004, 30 (02) : 459 - 468
  • [4] Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
    Archibald, Luke
    Brunette, Mary F.
    Wallin, Diana J.
    Green, Alan I.
    ALCOHOL RESEARCH-CURRENT REVIEWS, 2019, 40 (01): : 51 - 59
  • [5] A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder
    Byerly, MJ
    Fisher, R
    Carmody, T
    Rush, AJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 997 - 1001
  • [6] Efficacy and tolerability of aripiprazole in outpatients with schizophrenia or schizoaffective disorder
    Shin, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S515 - S515
  • [7] Use of the CAGE questionnaire in older adults with schizophrenia or schizoaffective disorder
    Lehman, MS
    Holohan, N
    Kettl, P
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 7 (03): : 269 - 269
  • [8] VITAMIN D DEFICIENCY IN DUTCH OUTPATIENTS WITH BIPOLAR DISORDER, SCHIZOAFFECTIVE DISORDER OR SCHIZOPHRENIA
    Schulte, Peter F. J.
    Boerman, Remco
    Cohen, Dan
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S164 - S164
  • [9] Subjective Quality of Life and Sexual Dysfunction in Outpatients With Schizophrenia or Schizoaffective Disorder
    Bushong, Mark E.
    Nakonezny, Paul A.
    Byerly, Matthew J.
    JOURNAL OF SEX & MARITAL THERAPY, 2013, 39 (04) : 336 - 346
  • [10] Treatment outcome of nicotine dependence comorbidity in outpatients with schizophrenia and schizoaffective disorder
    Vilibic, M
    Smale, VF
    Jacic, D
    Henigsberg, N
    Uzun, S
    Mimica, N
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 226 - 226